Ask Us
Please correct the highlighted fields below.

Safety Alert: Ibandronate Sodium

Update on FDA Safety Review of Bisphosphonates

What does this mean?

Despite previous concerns regarding the use of bisphosphonates and abnormal heart rhythms, the results of the FDA's safety review should be reassuring if you are still using Ibandronate (Boniva).

The FDA has issued a finalized safety review on bisphosphonates, like Ibandronate (Boniva), and found no link between these medications and atrial fibrillation - an abnormal heart rhythm commonly known as "afib".

Bisphosphonates are a type of medicine commonly used to treat patients with osteoporosis.

For more information please visit:

more information here

Source: FDA
Publication Date: 2008-11-14
Last Updated: 2009-12-05

Visit the medication page for the following drugs:
Ibandronate Sodium medication page

Tell a friend

DISCLAIMER: MediGuard is not intended to be a substitute for professional medical advice. MediGuard cannot and does not take into consideration every possible interaction or account for individual responses to medicine. Different individuals may respond to medication in different ways. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Always seek the advice of a qualified health provider with any questions you may have before making any changes to your treatment. The use of the MediGuard site and its content is at your own risk. The MediGuard site and the information contained in it is intended for users in the United States and information in other countries may be different.

Popular Terms: Lisinopril Side Effects, Plavix Side Effects, Copaxone Information, Metformin, Methotrexate Interactions

HACKER SAFE certified sites prevent over 99.9% of hacker crime.